Impact of current cough on health-related quality of life in patients with COPD

Background Cough and sputum production are frequent in chronic obstructive pulmonary disease (COPD). The objective of this study was to examine the relationship between cough and sputum production and health-related quality of life in COPD. Methods A cross-sectional study was conducted in the French Initiatives COPD cohort and assessed cough and sputum production within the past 7 days using the cough and sputum assessment questionnaire (CASA-Q), health-related quality of life, spirometry, smoking status, dyspnea, exacerbations, anxiety and depression, and comorbidities. Results One hundred and seventy-eight stable COPD patients were included (age, 62 [56–69] years, 128 male, forced expiratory volume in 1 second [FEV1]: 57 [37–72] % predicted) (median [Q1–Q3]). In univariate analyses, health-related quality of life (Saint George’s respiratory questionnaire total score) was associated with each CASA-Q domain and with chronic bronchitis, exacerbations, dyspnea, FEV1, depression, and anxiety. All four domains introduced separately were independently associated with health-related quality of life. When introduced together in multivariate analyses, only the cough impact domain remained independently associated with health-related quality of life (R2=0.60). With chronic bronchitis (standard definition) instead of the CASA-Q, the R2 was lower (R2=0.54). Conclusion This study provides evidence that current cough in the previous 7 days is an important determinant of health-related quality of life impairment in stable COPD patients.

[1]  V. Kim,et al.  Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. , 2015, Annals of the American Thoracic Society.

[2]  V. Kim,et al.  The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. , 2015, Current opinion in pulmonary medicine.

[3]  A. Lindberg,et al.  Subjects with COPD and productive cough have an increased risk for exacerbations and death. , 2015, Respiratory medicine.

[4]  D. Lynch,et al.  Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. , 2014, American journal of respiratory and critical care medicine.

[5]  D. Lynch,et al.  Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study , 2014, Respiratory Research.

[6]  D. Postma,et al.  Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH , 2014, Occupational and Environmental Medicine.

[7]  Ignasi Serra,et al.  Lifetime Occupational Exposure to Dusts, Gases and Fumes Is Associated with Bronchitis Symptoms and Higher Diffusion Capacity in COPD Patients , 2014, PloS one.

[8]  M. Schlesser,et al.  Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross‐sectional multicentre study , 2013, International journal of clinical practice.

[9]  I. Wiklund,et al.  Content Validity of CASA-Q Cough Domains and UCSD-SOBQ for Use in Patients with Idiopathic Pulmonary Fibrosis , 2013, Global journal of health science.

[10]  Ashley Woodcock,et al.  Predictors of objective cough frequency in chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[11]  M. Pistolesi,et al.  Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD , 2012, European Respiratory Journal.

[12]  A. Menezes,et al.  The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study , 2012, European Respiratory Journal.

[13]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[14]  B. Monz,et al.  Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. , 2010, Respiratory medicine.

[15]  S. Guerra,et al.  Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk , 2009, Thorax.

[16]  Nicolas Roche,et al.  Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. , 2009, Chest.

[17]  H. Magnussen,et al.  Development and validation of a cough and sputum assessment questionnaire. , 2008, Respiratory Medicine.

[18]  A. Nissinen,et al.  Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. , 2006, Chest.

[19]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[20]  M. Miravitlles,et al.  Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis , 2000, Respiration.

[21]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[22]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[23]  P. Schnohr,et al.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. , 1990, Thorax.

[24]  F. Kauffmann,et al.  Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. , 1986, The American review of respiratory disease.